Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Agile Therapeutics, Inc. (AGRX)

« Back to company index

AGRX Chatter Timeline

Stock Ticker for AGRX

Most Active Tweeters for AGRX

UserTweets
@LlcBillionaire 8
@proactive_NA 3
@BioDonor 3
@MaisaCorp 2
@TraderTexMex 2

Recent Tweets for AGRX

Lucy3370 @Lucy3370
$agrx said they have $ to last into 4th qtr. PDUFA is Nov. they r going to either have to 1. Sell company 2. Part… https://t.co/rb09wv3DYv
May 23rd 2019, 10:05am
rogerthat191 @rogerthat191
$AGRX bought some. Chart ugly. Will look to add more around a buck or lower if mkt craps pants https://t.co/474ArtoK6i
May 23rd 2019, 9:05am
fda_tracker @fda_tracker
$AGRX New PDUFA Date 2019-11-16 AGILE THERAPEUTICS INC Link:https://t.co/jkcHc0gbIe Calendar:https://t.co/sCt1qKoMdr
May 23rd 2019, 9:05am
MaisaCorp @MaisaCorp
$AGRX Announces FDA Acceptance of the NDA Resubmission of Twirla. FDA Assigns Prescription Drug User Fee Act (P… https://t.co/FKEgoEHT0J
May 22nd 2019, 4:05pm
AgileTher @AgileTher
$AGRX News: #FDA Accepts #Twirla #NDA Resubmission for Review. #PDUFA 11/16/2019. https://t.co/k8aZIuZC1h https://t.co/lOVrtt6DWi
May 22nd 2019, 11:05am
bulletin_en @bulletin_en
Sterling Capital Management Upped Its Macquarie Infrastructure Co Tr $MIC Stake; Algorx Pharmaceuticals $AGRX Senti… https://t.co/0tdV7BBUnA
May 22nd 2019, 11:05am
bulletin_en @bulletin_en
Engineers Gate Manager LP Has Lowered Its Lincoln Natl Ind $LNC Stake; AGILE THERAPEUTICS $AGRX Has 0.46 Sentiment https://t.co/bsqU5HUeAF
May 22nd 2019, 11:05am
StockNewsNow @StockNewsNow
$AGRX Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® https://t.co/E35Gm9UNNJ
May 22nd 2019, 10:05am
Madeforprofit1 @Madeforprofit1
$AGRX FDA acceptance news soon $2+++++++++++++=== 100% upside ???? https://t.co/UdQP3Ay3uV
May 22nd 2019, 10:05am
Madeforprofit1 @Madeforprofit1
$AGRX FDA acceptance news soon $2+++++++++++?????? https://t.co/0zDDlMy6cS
May 22nd 2019, 10:05am
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $AGRX ... https://t.co/mnYaiRq1wk
May 22nd 2019, 9:05am
TradeSmartStock @TradeSmartStock
$AGRX Big news this morning... volume surge could send this to $2 https://t.co/ipwx8bZS8r
May 22nd 2019, 9:05am
tradnews_ @tradnews_
RT @OpenOutcrier: $AGRX (+5.7% pre) Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® - SI https://t.co/xsQYA…
May 22nd 2019, 8:05am
OpenOutcrier @OpenOutcrier
$AGRX (+5.7% pre) Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® - SI https://t.co/xsQYAMOVSX
May 22nd 2019, 8:05am
LlcBillionaire @LlcBillionaire
$AGRX had good news this morning
May 22nd 2019, 8:05am
TeamBrazil2015 @TeamBrazil2015
@TradeSmartStock Trying to grab a few now $AGRX
May 22nd 2019, 8:05am
proactive_NA @proactive_NA
$AGRX FDA accepts Agile Therapeutics's new drug application for contraceptive patch Twirla https://t.co/pOd4X5BVwY… https://t.co/fEXx8gWWq8
May 22nd 2019, 7:05am
BioDonor @BioDonor
RT @TraderTexMex: $AGRX 5 days from submission to acceptance PR. November 16th PDUFA
May 22nd 2019, 7:05am
BioBreakout @BioBreakout
$AGRX Agile Therapeutics Says FDA Accepts Twirla NDA, PDUFA November 16, 2019
May 22nd 2019, 7:05am
bihan35 @bihan35
RT @BioStocks: $AGRX Announces FDA Acceptance of the NDA Resubmission of Twirla. PDUFA 11/16/19
May 22nd 2019, 7:05am
PhilKobi @PhilKobi
$AGRX 5 Days from submission to acceptance and pdufa assignment. Seems unusually quick response from FDA. What ca… https://t.co/wwVSL0eGXx
May 22nd 2019, 7:05am
pennystocksusa @pennystocksusa
RT @BioDonor: $AGRX FDA accepts the NDA Resubmission of Twirla https://t.co/3jdD8NOjRD
May 22nd 2019, 7:05am
BioDonor @BioDonor
$AGRX FDA accepts the NDA Resubmission of Twirla https://t.co/3jdD8NOjRD
May 22nd 2019, 7:05am
TraderTexMex @TraderTexMex
$AGRX 5 days from submission to acceptance PR. November 16th PDUFA
May 22nd 2019, 7:05am
BankTheTrade @BankTheTrade
$AGRX today announced that the U.S. Food and Drug Administration ( FDA ) has accepted for review the Company’s Ne… https://t.co/GlABBTDRRC
May 22nd 2019, 7:05am
BioStocks @BioStocks
$AGRX Announces FDA Acceptance of the NDA Resubmission of Twirla. PDUFA 11/16/19
May 22nd 2019, 7:05am
Amp_Trades @Amp_Trades
$AGRX Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
May 22nd 2019, 7:05am
WKRBNews @WKRBNews
Agile Therapeutics $AGRX Lifted to “Hold” at ValuEngine https://t.co/wLPiQZtqBf #markets
May 21st 2019, 7:05am
ZolmaxNews @ZolmaxNews
Agile Therapeutics’ $AGRX “Buy” Rating Reaffirmed at Maxim Group https://t.co/8vxJ2WSF0F
May 21st 2019, 1:05am
WeekHerald @WeekHerald
Agile Therapeutics $AGRX Upgraded to “Hold” at ValuEngine https://t.co/o7dg4SwjaZ
May 21st 2019, 12:05am
LlcBillionaire @LlcBillionaire
$AGRX it’s dropping
May 20th 2019, 9:05pm
proactive_NA @proactive_NA
$AGRX Agile Therapeutics makes all-out push for flagship contraceptive patch Twirla https://t.co/cCBikZMgYK via… https://t.co/PGUdNqoEjt
May 20th 2019, 12:05pm
WeekHerald @WeekHerald
Agile Therapeutics’ $AGRX “Buy” Rating Reaffirmed at Maxim Group https://t.co/xKw2hs22zf
May 20th 2019, 2:05am
AmericanBanking @AmericanBanking
Zacks: Brokerages Anticipate Agile Therapeutics Inc $AGRX to Announce -$0.11 Earnings Per Share https://t.co/I7D5c9IsFX #stocks
May 19th 2019, 10:05pm
TranscriptDaily @TranscriptDaily
Brokerages Expect Agile Therapeutics Inc $AGRX Will Announce Earnings of -$0.11 Per Share https://t.co/tLInVnAy2n
May 19th 2019, 10:05pm
LlcBillionaire @LlcBillionaire
$AGRX under the 20 MA here on watch
May 19th 2019, 12:05pm
registrarjourn @registrarjourn
Agile Therapeutics’ $AGRX Buy Rating Reiterated at Maxim Group https://t.co/C3sdFwJaRi
May 19th 2019, 3:05am
EnterpriseLeade @EnterpriseLeade
Agile Therapeutics’ $AGRX Buy Rating Reiterated at Maxim Group https://t.co/8COc3eCjf7
May 19th 2019, 3:05am
AmericanBanking @AmericanBanking
Agile Therapeutics $AGRX Given Buy Rating at Maxim Group https://t.co/oVh12McKTY #stocks
May 18th 2019, 2:05pm
dispatchtribune @dispatchtribune
Agile Therapeutics’ $AGRX Buy Rating Reiterated at Maxim Group https://t.co/LBiMSqEV2s
May 18th 2019, 2:05pm
crusadernz @crusadernz
Biotech updates 05/17: $AGRX resubmits Twirla NDA (previous CRLs 2013/2017) $ABBV fails late-stage glioblastoma tr… https://t.co/kVPrkB9YcJ
May 17th 2019, 9:05pm
HottestStockNow @HottestStockNow
$AGRX Resubmits NDA to the FDA for Its Transdermal Low-Dose Contraceptive Patch Twirla https://t.co/Yi5jUk7UjG
May 17th 2019, 8:05pm
MaisaCorp @MaisaCorp
$AGRX resubmitted to the US Food and Drug Administration a new drug application (NDA) for its product candidate,… https://t.co/BNaBPTiNga
May 17th 2019, 4:05pm
fintel_io @fintel_io
$AGRX / Agile Therapeutics files form 8-K https://t.co/fVrPyJYiLh
May 17th 2019, 12:05pm
fintel_io @fintel_io
Also, if you are new to $AGRX here's some background for you https://t.co/y4wXsvLxT2
May 17th 2019, 12:05pm
AlAltomari @AlAltomari
RT @AgileTher: #BREAKING: $AGRX has resubmitted the #NDA for its investigational, once-weekly prescription contraceptive patch Twirla® (AG2…
May 17th 2019, 11:05am
StockNewsNow @StockNewsNow
$AGRX Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twi… https://t.co/UD5mwsGSdD
May 17th 2019, 10:05am
NewsQuantified @NewsQuantified
$AGRX Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla, stock inclines… https://t.co/jGBTmzDsOL
May 17th 2019, 9:05am
ooapieceovcandy @ooapieceovcandy
RT @TraderTexMex: $AGRX Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
May 17th 2019, 9:05am
proactive_NA @proactive_NA
$AGRX Agile Therapeutics resubmits new drug application for Twirla contraceptive patch to FDA… https://t.co/Uq5sV0s7Qb
May 17th 2019, 8:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.